InvestorsHub Logo
Followers 20
Posts 1107
Boards Moderated 0
Alias Born 08/28/2012

Re: Alleyba1 post# 18297

Saturday, 06/14/2014 2:42:17 PM

Saturday, June 14, 2014 2:42:17 PM

Post# of 24848
I agree Alleyba, Mr. Schneiderman's decisions are truly directing SCRC in the right direction. I was really surprised to hear his enthusiasm for RapiMeds in the China market. It was the first we heard anything in months. What Mr. Schneiderman is doing with the compound pharmacy business is incredible. MAP was doing nothing until SCRC came around and then $1.6M in revenues last month. Based on everything mentioned in the interview SCRC is moving towards becoming a $30 - $40M company. Not bad at all. GO SCRC!!!